Adjuvant Capital

Adjuvant Capital is a US-based life sciences investment fund that finances companies developing innovative drugs, vaccines, diagnostics, and medical devices to combat critical global public health challenges. The fund supports ambitious biotechnology and healthcare companies working on solutions that address unmet medical needs in underserved populations worldwide.

Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges.